… data from The International Severe Asthma Registry (ISAR) … experienced a significant
reduction in the number of severe … with severe eosinophilic asthma and a history of omalizumab …

… of clinically significant and severe asthma exacerbations and … in Spain in 345 adult patients
with severe persistent asthma … of OCS after 12 months of omalizumab therapy, and reported …

… A /L at the start of omalizumab treatment. Most had experienced anaphylaxis by accidental
… Patients with total IgE >1500 kUA/L, controlled severe asthma, and previous anaphylactic …

… However, long-term data from the real-life experience of … population were analysed using
methods of descriptive statistics. … treatment in Poland from 50 severe asthma treatment centers…

… significant episodes of exacerbation per patient-year in high-risk of serious asthma-related …
prior to omalizumab treatment [31]. Overall, our result is in line with the eXpeRience registry, …

… Methods A multicenter, real-life study involving severe asthma patients in Spain. Various …
Recently, in the German severe asthma registry Milger et al. demonstrated that clinical …

… asthma based on methods such as unsupervised clustering … an acute tertiary care hospital
in Badalona (Barcelona, Spain… of patients who did not experience any exacerbation. On the …

… The aim of our study is to evaluate the safety of biological therapy (omalizumab, … Patients
and methods … with the biological therapies currently available in Spain, offering new data on …

… These patients experience the highest overall morbidity, as … in Valencia, Spain, the direct
cost of severe asthma per patient … Omalizumab therapy in the long term—after 3–10 years of …

… In 2015 omalizumab was the most commonly used biologic … Interestingly, a recent Spanish
initiative was launched that … missing data structure require novel approaches to analysis [65]. …